Opus Genetics, Inc. (IRD) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2001: $3.89M2002: $2.71M2003: $2.48M2004: -$564.2K2005: $4.83M2006: $3.21M2007: $958.2K2008: -$2.60M2009: $4.90M2010: $10.40M2011: $10.71M2012: $9.53M2013: $12.63M2014: $26.58M2015: $18.78M2016: $17.06M2017: $16.77M2018: -$1.70M2019: -$7.56M2020: -$13.47M2021: $22.22M2022: $46.24M2023: $49.91M2024: $6.72M2025: $15.35M$15.35M
2001Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$15.35M+128.3%
2024$6.72M-86.5%
2023$49.91M+7.9%
2022$46.24M+108.1%
2021$22.22M+265.0%
2020-$13.47M-78.1%
2019-$7.56M-345.0%
2018-$1.70M-110.1%
2017$16.77M-1.7%
2016$17.06M-9.1%
2015$18.78M-29.4%
2014$26.58M+110.5%
2013$12.63M+32.4%
2012$9.53M-10.9%
2011$10.71M+3.0%
2010$10.40M+112.0%
2009$4.90M+288.4%
2008-$2.60M-371.6%
2007$958.2K-70.2%
2006$3.21M-33.5%
2005$4.83M+956.0%
2004-$564.2K-122.8%
2003$2.48M-8.7%
2002$2.71M-30.3%
2001$3.89M